JP2022545655A5 - - Google Patents

Info

Publication number
JP2022545655A5
JP2022545655A5 JP2022510108A JP2022510108A JP2022545655A5 JP 2022545655 A5 JP2022545655 A5 JP 2022545655A5 JP 2022510108 A JP2022510108 A JP 2022510108A JP 2022510108 A JP2022510108 A JP 2022510108A JP 2022545655 A5 JP2022545655 A5 JP 2022545655A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
sequence
amino acid
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022510108A
Other languages
English (en)
Japanese (ja)
Other versions
JP7585305B2 (ja
JP2022545655A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/046335 external-priority patent/WO2021034646A1/en
Publication of JP2022545655A publication Critical patent/JP2022545655A/ja
Publication of JP2022545655A5 publication Critical patent/JP2022545655A5/ja
Application granted granted Critical
Publication of JP7585305B2 publication Critical patent/JP7585305B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022510108A 2019-08-17 2020-08-14 多量体の二重特異性抗cd123結合分子及びその使用 Active JP7585305B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962888475P 2019-08-17 2019-08-17
US62/888,475 2019-08-17
US201962888702P 2019-08-19 2019-08-19
US62/888,702 2019-08-19
PCT/US2020/046335 WO2021034646A1 (en) 2019-08-17 2020-08-14 Multimeric bispecific anti-cd123 binding molecules and uses thereof

Publications (3)

Publication Number Publication Date
JP2022545655A JP2022545655A (ja) 2022-10-28
JP2022545655A5 true JP2022545655A5 (cg-RX-API-DMAC7.html) 2023-06-16
JP7585305B2 JP7585305B2 (ja) 2024-11-18

Family

ID=74659605

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510108A Active JP7585305B2 (ja) 2019-08-17 2020-08-14 多量体の二重特異性抗cd123結合分子及びその使用

Country Status (10)

Country Link
US (1) US20220289856A1 (cg-RX-API-DMAC7.html)
EP (1) EP4013796A4 (cg-RX-API-DMAC7.html)
JP (1) JP7585305B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220045030A (cg-RX-API-DMAC7.html)
CN (1) CN114341179B (cg-RX-API-DMAC7.html)
AU (1) AU2020334882A1 (cg-RX-API-DMAC7.html)
CA (1) CA3147767A1 (cg-RX-API-DMAC7.html)
IL (1) IL289964A (cg-RX-API-DMAC7.html)
MX (1) MX2022002024A (cg-RX-API-DMAC7.html)
WO (1) WO2021034646A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4011910A1 (en) 2014-04-03 2022-06-15 IGM Biosciences, Inc. Modified j-chain
PT3247728T (pt) 2015-01-20 2020-07-16 Igm Biosciences Inc Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas
WO2016154593A1 (en) 2015-03-25 2016-09-29 Igm Biosciences, Inc. Multi-valent hepatitis b virus antigen binding molecules and uses thereof
ES2819870T3 (es) 2015-09-30 2021-04-19 Igm Biosciences Inc Moléculas de unión con cadena J modificada
PT3355913T (pt) 2015-09-30 2024-12-18 Igm Biosciences Inc Moléculas de ligação com cadeia j modificada
CN111787951B (zh) 2018-03-01 2025-06-17 Igm生物科学股份有限公司 影响IgM血清半衰期的IgM Fc和J链突变
KR20220035369A (ko) 2019-06-07 2022-03-22 아디맵 엘엘씨 고 친화도 항-cd3 항체, 및 이의 생성 및 사용 방법
EP4294829A4 (en) * 2021-02-17 2025-03-19 IGM Biosciences Inc. ANTI-CD123 BINDING MOLECULES AND THEIR USES
WO2022212191A1 (en) * 2021-04-01 2022-10-06 Modernatx, Inc. Mucosal expression of antibody structures and isotypes by mrna
EP4380693A1 (en) * 2021-08-06 2024-06-12 Universität Basel Discernible cell surface protein variants for use in cell therapy
CA3231006A1 (en) * 2021-09-17 2023-03-23 Adimab, Llc Anti-cd3 antibodies

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045774A (en) * 1997-01-10 2000-04-04 Epicyte Pharmaceutical Inc. J chain polypeptide targeting molecule linked to an imaging agent
SI3030575T1 (sl) * 2013-08-08 2018-11-30 Cytune Pharma Modulokini na osnovi IL-15 in IL-15R-alfa sushi domene
EP4011910A1 (en) * 2014-04-03 2022-06-15 IGM Biosciences, Inc. Modified j-chain
US10259887B2 (en) * 2014-11-26 2019-04-16 Xencor, Inc. Heterodimeric antibodies that bind CD3 and tumor antigens
AR103488A1 (es) * 2015-01-23 2017-05-10 Sanofi Sa Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123
ES2819870T3 (es) * 2015-09-30 2021-04-19 Igm Biosciences Inc Moléculas de unión con cadena J modificada
PT3355913T (pt) * 2015-09-30 2024-12-18 Igm Biosciences Inc Moléculas de ligação com cadeia j modificada
EP3464365A1 (en) 2016-06-01 2019-04-10 Xencor, Inc. Bispecific antibodies that bind cd123 and cd3
CA3055790A1 (en) * 2017-04-07 2018-10-11 Igm Biosciences, Inc. Modified human igm constant regions for modulation of complement-dependent cytolysis effector function
CN110913895B (zh) * 2017-05-08 2024-04-02 阿迪马布有限责任公司 抗cd3结合结构域和包含它们的抗体以及它们的产生及使用方法
CN108409840B (zh) * 2017-05-18 2020-06-23 重庆精准生物技术有限公司 抗cd123单链抗体及其组合的嵌合抗原受体和应用
CN111787951B (zh) * 2018-03-01 2025-06-17 Igm生物科学股份有限公司 影响IgM血清半衰期的IgM Fc和J链突变

Similar Documents

Publication Publication Date Title
JP7551693B2 (ja) NKp46結合タンパク質の可変領域
US12448423B2 (en) Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains
CN113874399B (zh) 抗ror1/抗cd3双特异性结合分子
JP6702893B2 (ja) 多重特異的抗原結合タンパク質
JP2022177090A5 (cg-RX-API-DMAC7.html)
US20210253736A1 (en) Heterodimeric antibodies that bind fibroblast activation protein
JP2019530640A5 (cg-RX-API-DMAC7.html)
CN112867734A (zh) 包含IL-15/IL-15Ra Fc融合蛋白和PD-1抗原结合结构域的靶向PD-1的异源二聚体融合蛋白及其用途
US20240199750A1 (en) Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging
JP2019528683A5 (cg-RX-API-DMAC7.html)
JP2018524326A (ja) 多重特異的nkエンゲイジャータンパク質
JP2018508214A5 (cg-RX-API-DMAC7.html)
JP2020510659A (ja) Cd16a指向性nk細胞エンゲージメント用タンデムダイアボディ
GB2519786A (en) Multivalent antigen-binding protein molecules
JP2021510736A5 (cg-RX-API-DMAC7.html)
AU2020334882A1 (en) Multimeric bispecific anti-CD123 binding molecules and uses thereof
JP2022549186A5 (cg-RX-API-DMAC7.html)
CN117616050A (zh) 与nkp46、细胞因子受体、肿瘤抗原和cd16a结合的多特异性蛋白质
JP2020536969A (ja) Cd3結合タンパク質の投薬レジメン
JP2025506341A5 (cg-RX-API-DMAC7.html)
Acheampong Bispecific antibody (bsAb) construct formats and their application in cancer therapy
WO2021231976A1 (en) Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
JP2023506834A5 (cg-RX-API-DMAC7.html)
JP2025511135A5 (cg-RX-API-DMAC7.html)
AU2024331754A1 (en) Anti-cd20 x anti-cd28 combination therapies